Dyrka K - Search Results

1

Central Diabetes Insipidus in Children as a Diagnostic Challenge.

Dyrka K, Dzialach L, Niedziela M, Jonczyk-Potoczna K, Derwich K, Obara-Moszynska M. Dyrka K, et al. Clin Pediatr (Phila). 2024 Sep;63(8):1044-1055. doi: 10.1177/00099228231202607. Epub 2023 Oct 5. Clin Pediatr (Phila). 2024. PMID: 37798950

2

The influence of growth hormone therapy on the cardiovascular system in Turner syndrome.

Dyrka K, Rozkiewicz N, Obara-Moszynska M, Niedziela M. Dyrka K, et al. J Pediatr Endocrinol Metab. 2020 Nov 26;33(11):1363-1372. doi: 10.1515/jpem-2020-0266. J Pediatr Endocrinol Metab. 2020. PMID: 33151179 Review.

3

Thyroid gland and direct-acting antivirals (DAAs) used to treat chronic hepatitis C. Is it a safe regimen?

Dyrka K, Borowska M, Czarnywojtek A. Dyrka K, et al. Pol Merkur Lekarski. 2022 Dec 22;50(300):388-390. Pol Merkur Lekarski. 2022. PMID: 36645687 Review.

4

Glioblastoma Multiforme: The Latest Diagnostics and Treatment Techniques.

Czarnywojtek A, Borowska M, Dyrka K, Van Gool S, Sawicka-Gutaj N, Moskal J, Kościński J, Graczyk P, Hałas T, Lewandowska AM, Czepczyński R, Ruchała M. Czarnywojtek A, et al. Among authors: dyrka k. Pharmacology. 2023;108(5):423-431. doi: 10.1159/000531319. Epub 2023 Jul 17. Pharmacology. 2023. PMID: 37459849 Free article. Review.

5

Endocrine abnormalities induced by the antiviral drugs and frequency of their occurrence.

Dyrka K, Miedziaszczyk M, Szałek E, Łącka K. Dyrka K, et al. Pol Merkur Lekarski. 2020 Jun 17;48(285):209-214. Pol Merkur Lekarski. 2020. PMID: 32564049 Review.

6

The influence of various endocrine disruptors on the reproductive system.

Czarnywojtek A, Borowska M, Dyrka K, Moskal J, Kościński J, Krela-Kaźmierczak I, Lewandowska AM, Abou Hjeily B, Gut P, Hoffmann K, Van Gool S, Sawicka-Gutaj N, Ruchała M. Czarnywojtek A, et al. Among authors: dyrka k. Endokrynol Pol. 2023;74(3):221-233. doi: 10.5603/EP.a2023.0034. Endokrynol Pol. 2023. PMID: 37695032 Free article. Review.

7

A NEW HYPOTHESIS IN THE TREATMENT OF RECURRENT GLIOBLASTOMA MULTIFORME (GBM). PART 2: IS THERE AN ALTERNATIVE THERAPY OPTION IN RECURRENT GM WHEN ALL STANDARD TREATMENTS HAVE BEEN EXHAUSTED?

Czarnywojtek A, Gut P, Sowiński J, Ruchała M, Ferlito A, Dyrka K. Czarnywojtek A, et al. Among authors: dyrka k. Pol Merkur Lekarski. 2023;51(4):433-435. doi: 10.36740/Merkur202304120. Pol Merkur Lekarski. 2023. PMID: 37756466

8

A NEW HYPOTHESIS IN THE TREATMENT OF RECURRENT GLIOBLASTOMA MULTIFORME (GBM). PART 1: INTRODUCTION.

Czarnywojtek A, Gut P, Borowska M, Dyrka K, Ruchała M, Ferlito A. Czarnywojtek A, et al. Among authors: dyrka k. Pol Merkur Lekarski. 2023;51(4):430-432. doi: 10.36740/Merkur202304119. Pol Merkur Lekarski. 2023. PMID: 37756465

9

Case Report: Efficacy and safety of recombinant growth hormone therapy in a girl with Loeys-Dietz syndrome.

Dyrka K, Jamsheer A, Bartecki M, Bobkowski W, Pawelec-Wojtalik M, Rajewska-Tabor J, Tomaszewska A, Balcerzak J, Aniol Z, Niedziela M, Obara-Moszynska M. Dyrka K, et al. Front Cardiovasc Med. 2025 Jan 3;11:1377510. doi: 10.3389/fcvm.2024.1377510. eCollection 2024. Front Cardiovasc Med. 2025. PMID: 39830008 Free PMC article.

10

Autoimmune thyroiditis: an update on treatment possibilities.

Dyrka K, Obara-Moszyńska M, Niedziela M. Dyrka K, et al. Endokrynol Pol. 2024;75(5):461-472. doi: 10.5603/ep.100701. Endokrynol Pol. 2024. PMID: 39475129 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

12 results

Search Page

Filters